Paul A. Brooke

Filings by Paul A. Brooke span 5 companies, the busiest being Incyte Corp, Ithaka Acquisition Corp and Viropharma Inc. Between 11 April 2007 and 31 March 2020, the trades on record add up to 78 filings.

The open-market side counts 26 purchases for €1.4M alongside 4 sales for €4.6M. Sales outweigh purchases by €3.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 29 share grants and 12 option exercises.

A typical purchase (the median) is worth €9,384.

The latest filing, published on 2 April 2020, reports a share grant of €22k in Incyte Corp. The last purchase on record was published on 20 January 2012, which is 5,390 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.